American Heart Association: Diuretic Cuts Morbidity, Mortality in Mild HF, Nancy University Study

MedPageToday -- CHICAGO -- Mildly symptomatic heart failure patients have better outcomes with the selective aldosterone-receptor blocker eplerenone (Inspra), a randomized controlled trial showed.

MORE ON THIS TOPIC